Bioceres Crop Solutions Corp. (BIOX) Stock Competitors & Peer Comparison
See (BIOX) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Inputs Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BIOX | $0.44 | +1.37% | 27.5M | -0.41 | -$1.06 | N/A |
| CTA-PB | $67.53 | +0.49% | 58.6B | N/A | N/A | +0.97% |
| CTVA | $75.01 | -1.12% | 50.2B | 40.55 | $1.85 | +0.97% |
| CTA-PA | $53.59 | -0.10% | 35.9B | N/A | N/A | +0.97% |
| NTR | $66.35 | -1.38% | 31.9B | 13.51 | $4.91 | +3.30% |
| CF | $108.58 | -0.79% | 16.7B | 9.78 | $11.10 | +1.86% |
| ICL | $5.59 | +0.00% | 7.2B | 26.62 | $0.21 | +3.43% |
| MOS | $21.28 | -0.47% | 6.8B | 152.00 | $0.14 | +4.13% |
| SMG | $59.62 | +3.63% | 3.5B | 17.13 | $3.48 | +4.43% |
| FMC | $11.50 | +3.60% | 1.4B | -0.59 | -$19.62 | +11.39% |
Stock Comparison
BIOX vs CTA-PB Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, CTA-PB has a market cap of 58.6B. Regarding current trading prices, BIOX is priced at $0.44, while CTA-PB trades at $67.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas CTA-PB's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.49%, compared to CTA-PB's ROE of +0.05%. Regarding short-term risk, BIOX is more volatile compared to CTA-PB. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CTA-PB's competition here
BIOX vs CTVA Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, CTVA has a market cap of 50.2B. Regarding current trading prices, BIOX is priced at $0.44, while CTVA trades at $75.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas CTVA's P/E ratio is 40.55. In terms of profitability, BIOX's ROE is -1.49%, compared to CTVA's ROE of +0.05%. Regarding short-term risk, BIOX is more volatile compared to CTVA. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CTVA's competition here
BIOX vs CTA-PA Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, CTA-PA has a market cap of 35.9B. Regarding current trading prices, BIOX is priced at $0.44, while CTA-PA trades at $53.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas CTA-PA's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.49%, compared to CTA-PA's ROE of +0.05%. Regarding short-term risk, BIOX is more volatile compared to CTA-PA. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CTA-PA's competition here
BIOX vs NTR Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, NTR has a market cap of 31.9B. Regarding current trading prices, BIOX is priced at $0.44, while NTR trades at $66.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas NTR's P/E ratio is 13.51. In terms of profitability, BIOX's ROE is -1.49%, compared to NTR's ROE of +0.09%. Regarding short-term risk, BIOX is more volatile compared to NTR. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check NTR's competition here
BIOX vs CF Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, CF has a market cap of 16.7B. Regarding current trading prices, BIOX is priced at $0.44, while CF trades at $108.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas CF's P/E ratio is 9.78. In terms of profitability, BIOX's ROE is -1.49%, compared to CF's ROE of +0.35%. Regarding short-term risk, BIOX is more volatile compared to CF. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CF's competition here
BIOX vs ICL Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, ICL has a market cap of 7.2B. Regarding current trading prices, BIOX is priced at $0.44, while ICL trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas ICL's P/E ratio is 26.62. In terms of profitability, BIOX's ROE is -1.49%, compared to ICL's ROE of +0.04%. Regarding short-term risk, BIOX is more volatile compared to ICL. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check ICL's competition here
BIOX vs MOS Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, MOS has a market cap of 6.8B. Regarding current trading prices, BIOX is priced at $0.44, while MOS trades at $21.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas MOS's P/E ratio is 152.00. In terms of profitability, BIOX's ROE is -1.49%, compared to MOS's ROE of +0.06%. Regarding short-term risk, BIOX is more volatile compared to MOS. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check MOS's competition here
BIOX vs SMG Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, SMG has a market cap of 3.5B. Regarding current trading prices, BIOX is priced at $0.44, while SMG trades at $59.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas SMG's P/E ratio is 17.13. In terms of profitability, BIOX's ROE is -1.49%, compared to SMG's ROE of -0.34%. Regarding short-term risk, BIOX is more volatile compared to SMG. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check SMG's competition here
BIOX vs FMC Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, FMC has a market cap of 1.4B. Regarding current trading prices, BIOX is priced at $0.44, while FMC trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas FMC's P/E ratio is -0.59. In terms of profitability, BIOX's ROE is -1.49%, compared to FMC's ROE of -0.83%. Regarding short-term risk, BIOX is less volatile compared to FMC. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check FMC's competition here
BIOX vs UAN Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, UAN has a market cap of 1.2B. Regarding current trading prices, BIOX is priced at $0.44, while UAN trades at $116.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas UAN's P/E ratio is 10.18. In terms of profitability, BIOX's ROE is -1.49%, compared to UAN's ROE of +0.40%. Regarding short-term risk, BIOX is more volatile compared to UAN. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check UAN's competition here
BIOX vs IPI Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, IPI has a market cap of 464.5M. Regarding current trading prices, BIOX is priced at $0.44, while IPI trades at $34.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas IPI's P/E ratio is 31.15. In terms of profitability, BIOX's ROE is -1.49%, compared to IPI's ROE of +0.03%. Regarding short-term risk, BIOX is more volatile compared to IPI. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check IPI's competition here
BIOX vs AVD Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, AVD has a market cap of 85.2M. Regarding current trading prices, BIOX is priced at $0.44, while AVD trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas AVD's P/E ratio is -1.87. In terms of profitability, BIOX's ROE is -1.49%, compared to AVD's ROE of -0.22%. Regarding short-term risk, BIOX is less volatile compared to AVD. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check AVD's competition here
BIOX vs BHST Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, BHST has a market cap of 52.3M. Regarding current trading prices, BIOX is priced at $0.44, while BHST trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas BHST's P/E ratio is -5.21. In terms of profitability, BIOX's ROE is -1.49%, compared to BHST's ROE of -0.88%. Regarding short-term risk, BIOX is more volatile compared to BHST. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check BHST's competition here
BIOX vs MULG Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, MULG has a market cap of 49.1M. Regarding current trading prices, BIOX is priced at $0.44, while MULG trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas MULG's P/E ratio is 18.21. In terms of profitability, BIOX's ROE is -1.49%, compared to MULG's ROE of +0.11%. Regarding short-term risk, BIOX is more volatile compared to MULG. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check MULG's competition here
BIOX vs BHIL-WT Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, BHIL-WT has a market cap of 49M. Regarding current trading prices, BIOX is priced at $0.44, while BHIL-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas BHIL-WT's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.49%, compared to BHIL-WT's ROE of -0.82%. Regarding short-term risk, BIOX is less volatile compared to BHIL-WT. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check BHIL-WT's competition here
BIOX vs CGA Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, CGA has a market cap of 29.3M. Regarding current trading prices, BIOX is priced at $0.44, while CGA trades at $1.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas CGA's P/E ratio is -0.98. In terms of profitability, BIOX's ROE is -1.49%, compared to CGA's ROE of +0.04%. Regarding short-term risk, BIOX is more volatile compared to CGA. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check CGA's competition here
BIOX vs LVRO Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, LVRO has a market cap of 15.1M. Regarding current trading prices, BIOX is priced at $0.44, while LVRO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas LVRO's P/E ratio is -0.03. In terms of profitability, BIOX's ROE is -1.49%, compared to LVRO's ROE of +11.90%. Regarding short-term risk, BIOX is more volatile compared to LVRO. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check LVRO's competition here
BIOX vs SEED Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, SEED has a market cap of 7.2M. Regarding current trading prices, BIOX is priced at $0.44, while SEED trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas SEED's P/E ratio is -1.35. In terms of profitability, BIOX's ROE is -1.49%, compared to SEED's ROE of +1.02%. Regarding short-term risk, BIOX is more volatile compared to SEED. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check SEED's competition here
BIOX vs AGRZ Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, AGRZ has a market cap of 6.2M. Regarding current trading prices, BIOX is priced at $0.44, while AGRZ trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas AGRZ's P/E ratio is 3.20. In terms of profitability, BIOX's ROE is -1.49%, compared to AGRZ's ROE of +0.37%. Regarding short-term risk, BIOX is less volatile compared to AGRZ. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check AGRZ's competition here
BIOX vs SVFD Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, SVFD has a market cap of 4.2M. Regarding current trading prices, BIOX is priced at $0.44, while SVFD trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas SVFD's P/E ratio is 0.07. In terms of profitability, BIOX's ROE is -1.49%, compared to SVFD's ROE of -367.30%. Regarding short-term risk, BIOX is less volatile compared to SVFD. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check SVFD's competition here
BIOX vs FMTO Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, FMTO has a market cap of 3.1M. Regarding current trading prices, BIOX is priced at $0.44, while FMTO trades at $3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas FMTO's P/E ratio is -0.00. In terms of profitability, BIOX's ROE is -1.49%, compared to FMTO's ROE of +75.78%. Regarding short-term risk, BIOX is less volatile compared to FMTO. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check FMTO's competition here
BIOX vs BHIL Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, BHIL has a market cap of 1.5M. Regarding current trading prices, BIOX is priced at $0.44, while BHIL trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas BHIL's P/E ratio is -0.01. In terms of profitability, BIOX's ROE is -1.49%, compared to BHIL's ROE of -0.82%. Regarding short-term risk, BIOX is more volatile compared to BHIL. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check BHIL's competition here
BIOX vs RKDA Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, RKDA has a market cap of 1.4M. Regarding current trading prices, BIOX is priced at $0.44, while RKDA trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas RKDA's P/E ratio is -0.15. In terms of profitability, BIOX's ROE is -1.49%, compared to RKDA's ROE of -2.19%. Regarding short-term risk, BIOX is less volatile compared to RKDA. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check RKDA's competition here
BIOX vs YTEN Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, YTEN has a market cap of 345.5K. Regarding current trading prices, BIOX is priced at $0.44, while YTEN trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas YTEN's P/E ratio is -0.02. In terms of profitability, BIOX's ROE is -1.49%, compared to YTEN's ROE of -15.08%. Regarding short-term risk, BIOX is less volatile compared to YTEN. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check YTEN's competition here
BIOX vs TNH Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, TNH has a market cap of 0. Regarding current trading prices, BIOX is priced at $0.44, while TNH trades at $83.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas TNH's P/E ratio is N/A. In terms of profitability, BIOX's ROE is -1.49%, compared to TNH's ROE of +0.43%. Regarding short-term risk, BIOX is more volatile compared to TNH. This indicates potentially higher risk in terms of short-term price fluctuations for BIOX.Check TNH's competition here
BIOX vs MBII Comparison June 2026
BIOX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BIOX stands at 27.5M. In comparison, MBII has a market cap of 0. Regarding current trading prices, BIOX is priced at $0.44, while MBII trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BIOX currently has a P/E ratio of -0.41, whereas MBII's P/E ratio is -6.82. In terms of profitability, BIOX's ROE is -1.49%, compared to MBII's ROE of -0.54%. Regarding short-term risk, BIOX is less volatile compared to MBII. This indicates potentially lower risk in terms of short-term price fluctuations for BIOX.Check MBII's competition here